Skip to main content
Livermore
Livermore
ZHEN

Neuberger Berman Group LLC

SEC CIK
0001465109
Latest filing
Aug 13, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Neuberger Berman Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
98,467
Value
$8.03M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of ARWR by Neuberger Berman Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202698,467$8.03M<0.1%−105,447−51.7%ReducedHolders
Q1 2026203,914$12.8M<0.1%+103,529+103.1%AddedHolders
Q4 2025100,385$6.66M<0.1%+87,000+650.0%AddedHolders
Q3 202513,385$461.6K<0.1%+733+5.8%AddedHolders
Q2 202512,652$199.9K<0.1%+12,652NewHolders
Q4 20240$00.0%−187,806−100.0%Sold outHolders
Q3 2024187,806$3.64M<0.1%+187,806NewHolders
Q1 20240$00.0%−167,847−100.0%Sold outHolders
Q4 2023167,847$5.14M<0.1%+38,773+30.0%AddedHolders
Q3 2023129,074$3.47M<0.1%−94,852−42.4%ReducedHolders
Q2 2023223,926$7.99M<0.1%−22,264−9.0%ReducedHolders
Q1 2023246,190$6.25M<0.1%+39,147+18.9%AddedHolders
Q4 2022207,043$8.40M<0.1%−51,444−19.9%ReducedHolders
Q3 2022258,487$8.54M<0.1%+9,935+4.0%AddedHolders
Q2 2022248,552$8.75M<0.1%−9,456−3.7%ReducedHolders
Q1 2022258,008$11.9M<0.1%−15,649−5.7%ReducedHolders
Q4 2021273,657$17.4M<0.1%−10,201−3.6%ReducedHolders
Q3 2021283,858$17.2M<0.1%+69,178+32.2%AddedHolders
Q2 2021214,680$17.2M<0.1%−30,000−12.3%ReducedHolders
Q1 2021244,680$15.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.